Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
SPECTRUM PHARMAC RG (NQ: SPPI)
19.65 USD  -0.70 (-3.44%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jun 21, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,377,411
Open 20.35
Bid (Size) 19.50 (500)
Ask (Size) 19.99 (2800)
Prev. Close 20.35
Today's Range 19.56 - 20.58
52wk Range 6.900 - 23.50
Shares Outstanding 104,055,102
Dividend Yield N/A
Performance
YTD
+3.10%
+3.10%
1 Month
+1.60%
+1.60%
3 Month
+12.22%
+12.22%
6 Month
+12.41%
+12.41%
1 Year
+175.21%
+175.21%
Top News
More News
Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2018 Global Healthcare Conference on June 6th
Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2018 Global Healthcare Conference on June 6th Read More
from Business Wire News Releases
CORRECTING and REPLACING Spectrum Pharmaceuticals Announces Detailed Results from Phase 3 Study of ROLONTIS® (eflapegrastim) Published in an ASCO Abstract
Spectrum Pharmaceuticals Announces Detailed Results from Phase 3 Study of ROLONTIS® (eflapegrastim) Published in an ASCO Abstract Read More
from Business Wire News Releases
More News
Read More
Sum Up The Pieces: IHE Could Be Worth $188
category ETFs
from ETF Channel
Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2018 Health Care Conference on May 16th
from Business Wire News Releases
Spectrum Pharmac Bearish Moving Average Crossover Alert (SPPI)
from Comtex SmarTrend® News Briefs
Spectrum Pharmaceuticals Reports First Quarter 2018 Financial Results and Pipeline Update
from Business Wire News Releases
Spectrum Pharmac Bearish Moving Average Crossover Alert (SPPI)
from Comtex SmarTrend® News Briefs
Spectrum Pharmaceuticals Announces Exclusive Licensing Agreement on Certain Methods of Use of Poziotinib with The University of Texas MD Anderson Cancer Center
from Business Wire News Releases
Spectrum Pharmaceuticals Enters into a Next-Generation Sequencing Companion Diagnostic Partnership with Thermo Fisher Scientific
from Business Wire News Releases
Bearish Moving Average Cross by Spectrum Pharmac (SPPI)
from Comtex SmarTrend® News Briefs
Spectrum Pharmaceuticals Announces Corporate Governance Enhancements and Board Changes
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.